Skip to main content
Caplight Logo









Innov2Learn

Innov2Learn

Private
Montreal, QuebecHealthcare & Life Scienceshttps://innov2learn.ca/

Last Round

Debt

May 1, 2026

Total Funding Raised

$230,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Innov2Learn is a health-care technology company that develops and manufactures realistic, Bluetooth-enabled medical simulation devices for healthcare training.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Computing Hardware

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

medical simulation deviceshealthcare simulationhigh-fidelity simulationtask trainersmedical device simulatorssimulation hardwarehealthcare educationapp-controlled simulatorssim lab equipmentnursing educationpoint-of-care simulatorsportable medical simulatorsparamedic trainingvital signs simulator

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Innov2Learn Comparables

Compare Innov2Learn with similar companies based on industry and business-model similarity.

Innov2Learn comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TruCorp
74%
3B Scientific
73%
CAE Inc.
73%

Innov2Learn Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtMay 1, 2026
GrantMar 1, 2023
GrantJun 1, 2022
GrantMar 4, 2022
AcceleratorJan 1, 2017

Key People

Founding team and executive leadership

Mike Boutin

CEO & Cofounder

Founding Team

Innov2Learn Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2026

    $128K raised from Centre d'entreprises et d'innovation de Montréal and Société d'Investissement Jeunesse.

  • Dec 11, 2024

    Grew 38% QoQ from 8 to 11 employees.

Innov2Learn Filings

Explore SEC and related filing metadata, where available.

Innov2Learn filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Innov2Learn's valuation, stock price, and market status.

Is Innov2Learn a public or private company?

Innov2Learn is a private company.

What is the current stock price of Innov2Learn?

Innov2Learn is a private company with no public stock price. No recent secondary market data is available.

How much is Innov2Learn worth (valuation)?

Valuation information for Innov2Learn is not publicly available.

Can I buy Innov2Learn stock?

Innov2Learn shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Innov2Learn's last funding round?

Innov2Learn's most recent funding round was Debt on May 1, 2026.

Who are the main investors in Innov2Learn?

Key investors in Innov2Learn include Ministère de l'Économie, de l'Innovation et de l'Énergie (MEIE), Centre d'entreprises et d'innovation de Montréal, Société d'Investissement Jeunesse, Centech.

Will Innov2Learn IPO soon?

No public IPO plans have been announced for Innov2Learn.

How can I track Innov2Learn secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Innov2Learn's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMontreal, Quebec
Employee Range9
Year Founded2015
Last FundingMay 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?